New drug launch sends Lupin shares soaring to record highs! Find out what’s next

Pallavi Madhiraju- September 5, 2024 0

Lupin Limited, a global pharmaceutical major, has seen its share price reach a 52-week high following the launch of its generic Mirabegron Extended-Release Tablets, 50 ... Read More

Zydus Lifesciences gets final FDA approval for Mirabegron generic

Pallavi Madhiraju- October 4, 2022 0

Zydus Lifesciences (previously Cadila Healthcare) said that its US subsidiary Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration (FDA) ... Read More